Package 51759-607-32

Brand: selarsdi

Generic: ustekinumab-aekn
NDC Package

Package Facts

Identity

Package NDC 51759-607-32
Digits Only 5175960732
Product NDC 51759-607
Product ID 51759-607_640e5a4e-13d5-4c59-8f37-41cd31fa4fc0
Description

1 TRAY in 1 CARTON (51759-607-32) / 1 SYRINGE, GLASS in 1 TRAY / 1 mL in 1 SYRINGE, GLASS

Marketing

Marketing Status
Marketed Since 2025-03-12
Brand selarsdi
Generic ustekinumab-aekn
Sample Package No

Linked Drug Pages (1)

Selarsdi ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["SUBCUTANEOUS"], "spl_id": "640e5a4e-13d5-4c59-8f37-41cd31fa4fc0", "openfda": {"unii": ["FU77B4U5Z0"], "rxcui": ["2705382", "2705389", "2705393", "2705398", "2705400", "2705401", "2726116", "2726118"], "spl_set_id": ["87f75b59-e48b-47c7-a4c0-5fe5965660e7"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 TRAY in 1 CARTON (51759-607-32)  / 1 SYRINGE, GLASS in 1 TRAY / 1 mL in 1 SYRINGE, GLASS", "package_ndc": "51759-607-32", "marketing_start_date": "20250312"}], "brand_name": "Selarsdi", "product_id": "51759-607_640e5a4e-13d5-4c59-8f37-41cd31fa4fc0", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Interleukin-12 Antagonist [EPC]", "Interleukin-12 Antagonists [MoA]", "Interleukin-23 Antagonist [EPC]", "Interleukin-23 Antagonists [MoA]"], "product_ndc": "51759-607", "generic_name": "ustekinumab-aekn", "labeler_name": "Teva Pharmaceuticals USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Selarsdi", "active_ingredients": [{"name": "USTEKINUMAB-AEKN", "strength": "90 mg/mL"}], "application_number": "BLA761343", "marketing_category": "BLA", "marketing_start_date": "20250312", "listing_expiration_date": "20261231"}